Reaction
Dengue Fever reporting signals
As of the last recalculation, Dengue Fever appears in 2,274 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is GOLIMUMAB (PRR 20.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Golimumab | 175 | 20.2 | 20.2 |
| Basiliximab | 17 | 13.3 | 13.3 |
| Dorzolamide Hydrochloride And Timolol Maleate | 10 | 11.6 | 11.6 |
| Dimenhydrinate | 13 | 11.2 | 11.2 |
| Ribociclib | 36 | 10.6 | 10.6 |
| Captopril | 10 | 9.6 | 9.6 |
| Amlodipine Besylate And Valsartan | 11 | 9.1 | 9.1 |
| Valsartan And Hydrochlorothiazide | 13 | 8.8 | 8.8 |
| Anastrozole Tablets | 20 | 8.6 | 8.6 |
| Belimumab | 27 | 7.9 | 7.9 |
| Valganciclovir Hydrochloride Powder, | 10 | 7.5 | 7.5 |
| Agalsidase Beta | 7 | 7.0 | 7.0 |
| Nilotinib | 22 | 6.9 | 6.9 |
| Anti-Thymocyte Globulin (Rabbit) | 6 | 6.8 | 6.8 |
| Losartan | 117 | 6.4 | 6.4 |
| Leucovorin Calcium | 13 | 6.3 | 6.3 |
| Tacrolimus Ointment 0.1% | 80 | 6.1 | 6.1 |
| Tacrolimus Extended-Release Capsules | 80 | 6.0 | 6.0 |
| Enalapril | 36 | 6.0 | 6.0 |
| Deferasirox | 17 | 5.9 | 5.9 |
| Insulin Glulisine | 6 | 5.4 | 5.4 |
| Eltrombopag Olamine | 13 | 5.2 | 5.2 |
| Rotigotine | 7 | 4.4 | 4.4 |
| Osimertinib | 14 | 4.0 | 4.0 |
| Upadacitinib | 35 | 4.0 | 4.0 |
| Somatropin | 30 | 3.8 | 3.8 |
| Secukinumab | 65 | 3.8 | 3.8 |
| Certolizumab Pegol | 47 | 3.7 | 3.7 |
| Brimonidine Tartrate | 7 | 3.6 | 3.6 |
| Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose | 3 | 3.4 | 3.4 |
| Paricalcitol | 5 | 3.2 | 3.2 |
| Alpelisib | 3 | 3.2 | 3.2 |
| Ustekinumab | 32 | 2.9 | 2.9 |
| Palivizumab | 4 | 2.4 | 2.4 |